Burkitt lymphoma following splenic marginal zone lymphoma: Evidence for two independent B-cell clones

Cancer Genetics and Cytogenetics

Volumn 141, Issue 1, 2003, Pages 86-88

  Heintel, Daniel ^a   Streubel, Berthold ^b   Welzel, Natascha ^a   Le, Trang ^a   Schwarzinger, Ilse ^b   Haas, Oskar A ^c   Simonitsch, Ingrid ^b   Lechner, Klaus ^a   Jaeger, Ulrich ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c CHILDREN'S CANCER RESEARCH INSTITUTE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN M;

AGED; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; BURKITT LYMPHOMA; CANCER GROWTH; CASE REPORT; CAUSE OF DEATH; CHROMOSOME DELETION; CHRONICITY; CLINICAL FEATURE; GENE SEQUENCE; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN GENE; IMMUNOPHENOTYPING; LYMPHOCYTE CLONE; MALE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SPLENECTOMY; SPLENIC MARGINAL ZONE LYMPHOMA;

AGED; B-LYMPHOCYTES; BURKITT LYMPHOMA; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 8; CLONE CELLS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; SPLENIC NEOPLASMS; TRANSLOCATION, GENETIC;

EID: 0037308571     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(02)00724-0     Document Type: Article

References (16)

1. Isaacson P.G., Piris M.A., Catovsky D., Swerdeo W.S., Montserat E., Berger F., Müller-Hermelink H.K., Nathwai B., Harris N.L. Splenic marginal zone lymphoma. Jaffe E.S., Harris N.L., Stein H., Vardiman J.W. World Health Organization classification of tumors. pathology and genetics of tumors of hematopoietic and lymphoid tissues:2001;135-137 IARC Press, Lyon.
2. H somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course. Blood. 99(4):2002;1299-1304.
3. Mateo M., Mollejo M., Villundas R., Algara P., Sanchez-Beato M., Martinez P., Piris M.A. 7q21-32 allelic loss is a frequent finding in splenic marginal zone lymphoma. Am J Pathol. 154(5):1999;1583-1589.
4. Troussard X., Valensi F., Duchayne E., Garand R., Felman P., Tulliez M., Henry-Amar M., Bryon P.A., Flandrin G., for the Groupe Francais d'Hematologie Cellulaire Splenic lymphoma with villous lymphocytes. clinical presentation, biology and prognostic factors in a series of 100 patients Br J Haematol. 93(3):1998;731-736.
5. Gruszka-Westwood A.M., Hamoudi R.A., Matues E., Tuset E., Catovsky D. p53 abnormalities in splenic lymphoma with villous lymphocytes. Blood. 97(11):2001;3552-3558.
6. Lloret E., Mollejo M., Mateo M.S., Villuendas R., Algara P., Martinez P., Piris M.A. Splenic marginal zone lymphoma with increased number of blasts. an aggressive variant? Hum Pathol. 30(10):1999;1153-1160.
7. Batanian J.R., Dunphy C.H., Richart J.M., Petruska P.J., Perkins S.L. Simultaneous presence of t(2;8)(p12;q24) and t(14;18)(q32;q21) in a B-cell lymphoproliferatve disorder with features suggestive of an aggressive variant of splenic marginal-zone lymphoma. Cancer Genet Cytogenet. 120:2000;136-140.
8. Kuwayama M., Machii T., Yamaguchi M., Yamaguti K., Kitani T., Kanakura Y. Blastic transformation of splenic lymphoma with villous lymphocytes after a well-controlled chronic phase of more than 10 years. Int J Hematol. 71(2):2000;167-171.
9. Hoelzer D., Thiel E., Ludwig W.D., Loffler H., Buchner T., Freund M., Heil G., Hiddemann W., Maschmeyer G., Volkers B., Aydemir U. The German multicenter trials for treatment of acute lymphoblastic leukemia in adults. The German adult ALL study group. Leukemia. 6(Suppl 2):1992;175-177.
10. Sham R.L., Phatak P., Carignan J., Janas J., Olson J.P. Progression of follicular large cell lymphoma to BurkittÄs lymphoma. Cancer. 63(3):1989;700-702.
11. Brito-Babapulle V., Crawford A., Khokhar T., Laffan M., Matues E., Fairhead S., Catovsky D. Translocations t(14;18) and t(8;14) with rearranged bcl-2 an myc in a case presenting as B-ALL (L3). Leukemia. 5(1):1991;83-87.
12. Wong K.F., Chu Y.C., Hui P.K. Splenic lymphoma with villous lymphocytes showing del(7) and inv(10). Cancer Genet Cytogenet. 102(2):1998;145-147.
13. Gruszka-Westwood AM, Hamoudi RA, Osborne L, Matutes E, Catovsky D. Deletion mapping on the long arm of chromosome 7 in splenic lymphoma with villous lymphocytes (SLVL). American Society of Hematology 43rd annual meeting and exposition. Orlando, FL, December 7-11, 2001.
14. Camacho F.I., Mollejo M., Mateo M.S., Algara P., Navas C., Hernandez J.M., Santoja C., Sole F., Sanchez-Beato M., Piris M.A. Progression to large B-cell lymphoma in splenic marginal zone lymphoma. a description of a series of 12 cases Am J Surg Pathol. 25(10):2001;1268-1276.
15. Nakamura N., Kuze T., Hashimoto Y., Hoshi S., Tominaga K., Sasaki Y., Shirakawa A., Sato M., Maeda K., Abe M. Analysis of the immunoglobulin heavy chain gene of secondary diffuse large B-cell lymphoma that subsequently developed in four cases with B-cell chronic lymphocytic leukaemia or lymphoplasmacytoid lymphoma (Richter syndrome). Pathol Int. 50(8):2000;636-643.
16. Matolcsy A., Inghirami G., Knowles D.M. Molecular genetic demonstration of the diverse evolution of Richter's syndrome (chronic lymphocytic leukaemia and subsequent large cell lymphoma). Blood. 83(5):1994;1363-1372.